Use of Partial Liquid Ventilation to Manage Pulmonary Complications of Acute Verapamil–Sustained Release Poisoning^*

Abstract

Introduction: Verapamil is a papaverine-derived calcium channel blocker widely used for the treatment of hypertension and supraventricular tachyarrhythmias. It is one of the leading agents involved in pharmaceutical poisoning-related deaths among adults. Case Report: We report a case of severe sustained-release verapamil poisoning associated with respiratory failure in an adult man who survived after receiving 4 days of partial liquid ventilation as a part of his medical management.